OCRA News

Baby Aspirin Associated with Lower Risk of Ovarian Cancer

(October 9, 2018) A study, published in JAMA Oncology, followed about 200,000 women over the course of 25 years in order to track their use of analgesics…

Read on

OCRA Funded Study Increased Genetic Counseling Referrals for Epithelial Ovarian Cancer Patients

(October 2, 2018) A study by the Mayo Clinic earlier this year aimed to increase the amount of genetic counseling referrals to epithelial ovarian cancer patients by supplying patients with a Genetics Referral Toolkit…

Read on

Super September New York City

(October 1) OCRA’s inaugural Super September shopping event took place on September 27-28 at Pier 17 in Manhattan…

Read on

OCRFA is now OCRA

(October 1, 2018) We’re shortening our name, to make it easier to say and easier to write. OCRFA is now Ovarian Cancer Research Alliance (OCRA). You can find us at ocrahope…

Read on

OCRFA Funded Research Identifies Biomarker Linked to HGSOC Treatment and Survival Outcomes

(September 21, 2018) In an international collaboration funded in part by OCRFA, published recently in Cell, researchers used proteomics, the large-scale study of proteins, to identify an important indicator for treatment and disease-free survival in…

Read on

Big Strides Made in Identifying More BRCA1 Mutations

(September 19, 2018) Researchers at the University of Washington recently made a breakthrough in identifying and confirming variants of the BRCA1 mutation, a gene mutation that increases a woman’s risk of breast and ovarian cancers…

Read on

Exploring the Importance of Glycogen in Cancer Metastasis

(September 14, 2018) A study published in Cell Metabolism explores the use of glycogen by ovarian cancer tumor cells, specifically in an area where metastasis happens quickly, the omentum…

Read on

Support Life-Saving Research for Ovarian Cancer Awareness Month

We need your help this September. Ovarian cancer is the fifth leading cause of cancer death among women, and is the deadliest of gynecologic cancers. #ResearchMatters. Research is the key to defeating this devastating disease…

Read on

New Clues on the Origins of Ovarian Cancer

(August 30, 2018) Researchers at Brigham and Women’s Hospital in Boston have found new clues to the origin of high-grade serous carcinoma (HGSC)…

Read on

OCRA’s Advocate Leader Program is now open. Apply today.

Be a voice for the ovarian cancer community. Update: The deadline to apply for our 2019 Advocate Leader program has now passed. (August 28, 2018) Registration is now open for our 2019 Advocate Leader program…

Read on

Non-BRCA Genes Associated with Breast and Ovarian Cancers Identified and Confirmed

(August 24, 2018) A recent study, published in JAMA Oncology, shed light on non-BRCA gene associations to breast and ovarian cancers…

Read on

Women with Medicare Found to Have Low Genetic Testing Rates

(August 23, 2018) Researchers from Vanderbilt Institute for Clinical and Translational Research recently conducted a study which focused on Medicare Part B recipients, those above the age of 65 or disabled, who were eligible for genetic testing…

Read on